BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10533728)

  • 21. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.
    Grossman SA; O'Neill A; Grunnet M; Mehta M; Pearlman JL; Wagner H; Gilbert M; Newton HB; Hellman R;
    J Clin Oncol; 2003 Apr; 21(8):1485-91. PubMed ID: 12697871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients.
    Boiardi A; Eoli M; Pozzi A; Salmaggi A; Broggi G; Silvani A
    Ital J Neurol Sci; 1999 Feb; 20(1):43-8. PubMed ID: 10933484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.
    Brandes AA; Scelzi E; Zampieri P; Rigon A; Rotilio A; Amista P; Berti F; Fiorentino MV
    Am J Clin Oncol; 1997 Aug; 20(4):364-7. PubMed ID: 9256890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
    Affronti ML; Heery CR; Herndon JE; Rich JN; Reardon DA; Desjardins A; Vredenburgh JJ; Friedman AH; Bigner DD; Friedman HS
    Cancer; 2009 Aug; 115(15):3501-11. PubMed ID: 19514083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatinum and BCNU chemotherapy in primary glioblastoma patients.
    Silvani A; Gaviani P; Lamperti EA; Eoli M; Falcone C; Dimeco F; Milanesi IM; Erbetta A; Boiardi A; Fariselli L; Salmaggi A
    J Neurooncol; 2009 Aug; 94(1):57-62. PubMed ID: 19212704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51.
    Rao RD; Krishnan S; Fitch TR; Schomberg PJ; Dinapoli RP; Nordstrom K; Scheithauer B; O'Fallon JR; Maurer MJ; Buckner JC
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):380-6. PubMed ID: 15667956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-irradiation chemotherapy for newly diagnosed high grade astrocytoma.
    Mathieu NT; Genet D; Labrousse F; Bouillet P; Denes SL; Martin J; Labourey JL; Venat L; Clavere P; Moreau JJ
    Anticancer Res; 2004; 24(2C):1249-53. PubMed ID: 15154655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
    Radiother Oncol; 1999 Apr; 51(1):27-33. PubMed ID: 10386714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium.
    Halperin EC; Herndon J; Schold SC; Brown M; Vick N; Cairncross JG; Macdonald DR; Gaspar L; Fischer B; Dropcho E; Rosenfeld S; Morowitz R; Piepmeier J; Hait W; Byrne T; Salter M; Imperato J; Khandekar J; Paleologos N; Burger P; Bentel GC; Friedman A
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):793-802. PubMed ID: 8598355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM).
    Balaña C; López-Pousa A; Berrocal A; Yaya-Tur R; Herrero A; García JL; Martín-Broto J; Benavides M; Cerdá-Nicolás M; Ballester R; Balart J; Capellades J
    J Neurooncol; 2004 Dec; 70(3):359-69. PubMed ID: 15662978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV; Buckner JC; Schomberg PJ; Cascino TL; Burch PA; Dinapoli RP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):297-302. PubMed ID: 9457812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy with carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas.
    Kiu MC; Chang CN; Cheng WC; Lin TK; Wong CW; Tang SG; Leung WM; Chen LH; Ho YS; Ng KT
    J Neurooncol; 1995; 25(3):215-20. PubMed ID: 8592171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
    Liau CT; Wei KC; Tseng CK; Jung SM
    Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence.
    Finlay JL; August C; Packer R; Zimmerman R; Sutton L; Freid A; Rorke L; Bayever E; Kamani N; Kramer E
    J Neurooncol; 1990 Dec; 9(3):239-48. PubMed ID: 1964962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
    J Neurooncol; 1994; 21(2):177-85. PubMed ID: 7861194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ; Malkin MG; Kleber M; Abrey LE
    Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU. A phase II trial.
    Recht L; Fram RJ; Strauss G; Fitzgerald TJ; Liepman M; Lew R; Kadish S; Sherman D; Wilson J; Greenberger J
    Am J Clin Oncol; 1990 Apr; 13(2):125-31. PubMed ID: 2156417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.